Table 1 Baseline characteristics of patients with nonvalvular atrial fibrillation in the non-anticoagulated and the anticoagulated cohorts
Non-anticoagulated cohort | Anticoagulated cohort | |
|---|---|---|
N = 154 | N = 911 | |
Age (years) | 74 ± 12 | 73 ± 11 |
Age ≥65 years, % | 127 (82.5) | 707 (77.6) |
Age ≥75 years, % | 75 (40.5) | 445 (48.8) |
Female sex, % | 81 (52.6) | 306 (33.6) |
Systolic blood pressure at study entry (mmHg) | 129 ± 15 | 139 ± 28 |
Current smoking, % | 53 (30.4) | 77 (8.5) |
Hypertension, % | 110 (71.4) | 678 (74.4) |
Diabetes mellitus, % | 33 (21.4) | 220 (24.1) |
Peripheral arterial disease, % | 20 (12.9) | 92 (10.1) |
Heart failure, % | 10 (6.5) | 343 (35.5) |
History of stroke or TIA, % | 9 (5.8) | 103 (11.3) |
Coronary artery disease, % | 23 (14.9) | 127 (13.9) |
COPD, % | 31 (20.1) | 183 (20.1) |
Hyperthyroidism, % | 2 (1.3) | 14 (1.5) |
Anemia, % | 27 (17.4) | 178 (19.5) |
Alcohol consumption ≥ 40 gr/daily, % | 9 (5.8) | 81 (8.9) |
Antiplatelets, % | 150 (97.4) | 23 (2.5) |
PINRR (%) | -- | 58 ± 18 |
eGFR < 60 ml/min/1.73 m2, % | 44 (28.6) | 311 (34.1) |
CHA2DS2-VASc | ||
0 point, % | 5 (3.2) | 62 (6.8) |
1 point, % | 18 (11.7) | 77 (8.4) |
≥ 2 points, % | 131 (85.1) | 772 (84.7) |
R2CHADS2 | ||
0 points, % | 22 (14.3) | 98 (10.8) |
1 points, % | 43 (27.9) | 142 (15.6) |
≥ 2 points, % | 89 (57.8) | 671 (73.7) |
ATRIA | ||
≤ 5 points, % | 79 (51.3) | 389 (42.7) |
6 points, % | 14 (9.1) | 115 (12.6) |
≥ 7 points, % | 61 (39.6) | 407 (44.7) |